The U.S. Department of Commerce has launched a Section 232 investigation into imports of personal protective and medical supplies, examining whether these imports pose a threat to national security. The outcome of this process could have significant implications for supply chains, trade policy, and health care access. Milton Koch, CPA, trade advisor at Buchanan Ingersoll & Rooney PC, shares insights on what the investigation means for health care providers and suppliers, and how organizations can most effectively engage.